Stoke Therapeutics (STOK) delivered earnings and revenue surprises of +29.82% and +181.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Wrexham striker Ollie Palmer has scored two goals in the space of a minute in stoppage time then converted one of the team’s ...

Two late Ollie Palmer goals see Wrexham come from behind to force penalties in the Carabao Cup first round and beat Hull in ...

Reports Q2 revenue $13.8M, consensus $5.2M. “This quarter was defined by strong execution that is driving momentum across our business,” said Ian ...

Good evening and welcome to our live coverage as the Reds return to the SToK Cae Ras in the Carabao Cup. Hull City are the opponents for Phil Parkinson's men tonight, kick-off is at 7.45pm and I'll be ...

If you don’t like getting soaked in the rains but still can’t stay away from travelling, consider visiting Ladakh to escape rains ...

Here’s how to watch the EFL Cup on TV and live stream. The Sporting News takes you through all the information you need to follow the game.

Stoke-on-Trent now has a 'front door we can be proud of' following a multi-million pound investment at Stoke Station, council ...

Wrexham forward Ryan Hardie says he apologised to his team-mates for missing a "crucial" chance at Southampton that might ...

Wrexham lost 2-1 at St. Mary's to the recently relegated Saints, with two late goals from Ryan Manning and Jack Stephens ...

Stumptown reigns supreme in the cold brew world, setting the gold standard that other brands aspire to match. Their ...

Analysts have given Stoke Therapeutics a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $29.0, indicating a potential 121.37% upside.